Literature DB >> 26653715

A computational framework for interspecies pharmacokinetics, exposure and toxicity assessment of gold nanoparticles.

Zhoumeng Lin1, Nancy A Monteiro-Riviere2, Raghuraman Kannan3, Jim E Riviere1.   

Abstract

AIM: To develop a comprehensive computational framework to simulate tissue distribution of gold nanoparticles (AuNP) across several species. MATERIALS &
METHODS: This framework was built on physiologically based pharmacokinetic modeling, calibrated and evaluated with multiple independent datasets.
RESULTS: Rats and pigs seem to be more appropriate models than mice in animal-to-human extrapolation of AuNP pharmacokinetics and that the dose and age should be considered. Incorporation of in vitro and/or in vivo cellular uptake and toxicity data into the model improved toxicity assessment of AuNP.
CONCLUSION: These results partially explain the current low translation rate of nanotechnology-based drug delivery systems from mice to humans. This simulation approach may be applied to other nanomaterials and provides guidance to design future translational studies.

Entities:  

Keywords:  PBPK modeling; biodistribution; computational nanotoxicology; endocytosis; nanomaterials; phagocytosis; physiologically based pharmacokinetic modeling; toxicokinetics

Mesh:

Substances:

Year:  2015        PMID: 26653715     DOI: 10.2217/nnm.15.177

Source DB:  PubMed          Journal:  Nanomedicine (Lond)        ISSN: 1743-5889            Impact factor:   5.307


  18 in total

1.  Probabilistic risk assessment of gold nanoparticles after intravenous administration by integrating in vitro and in vivo toxicity with physiologically based pharmacokinetic modeling.

Authors:  Yi-Hsien Cheng; Jim E Riviere; Nancy A Monteiro-Riviere; Zhoumeng Lin
Journal:  Nanotoxicology       Date:  2018-04-14       Impact factor: 5.913

Review 2.  Physiologically Based Pharmacokinetic (PBPK) Modeling of Pharmaceutical Nanoparticles.

Authors:  Min Li; Peng Zou; Katherine Tyner; Sau Lee
Journal:  AAPS J       Date:  2016-11-10       Impact factor: 4.009

3.  Translating Nanomedicine to Comparative Oncology-the Case for Combining Zinc Oxide Nanomaterials with Nucleic Acid Therapeutic and Protein Delivery for Treating Metastatic Cancer.

Authors:  R K DeLong; Yi-Hsien Cheng; Paige Pearson; Zhoumeng Lin; Calli Coffee; Elza Neelima Mathew; Amanda Hoffman; Raelene M Wouda; Mary Lynn Higginbotham
Journal:  J Pharmacol Exp Ther       Date:  2019-04-30       Impact factor: 4.030

4.  Short- and long-term effect of colorectal cancer targeting peptides conjugated to gold nanoparticles in rats' liver and colon after single exposure.

Authors:  Olusola B Adewale; Lynn Cairncross; Hlumisa Xakaza; Nicolas Wickens; Scholastica O Anadozie; Hajierah Davids; Saartjie Roux
Journal:  Toxicol Res       Date:  2021-10-26

5.  Predicting Nanoparticle Delivery to Tumors Using Machine Learning and Artificial Intelligence Approaches.

Authors:  Zhoumeng Lin; Wei-Chun Chou; Yi-Hsien Cheng; Chunla He; Nancy A Monteiro-Riviere; Jim E Riviere
Journal:  Int J Nanomedicine       Date:  2022-03-24

6.  The biocorona: a challenge for the biomedical application of nanoparticles.

Authors:  Jonathan Shannahan
Journal:  Nanotechnol Rev       Date:  2017-01-20       Impact factor: 7.848

7.  Environmental Risk Assessment Strategy for Nanomaterials.

Authors:  Janeck J Scott-Fordsmand; Willie J G M Peijnenburg; Elena Semenzin; Bernd Nowack; Neil Hunt; Danail Hristozov; Antonio Marcomini; Muhammad-Adeel Irfan; Araceli Sánchez Jiménez; Robert Landsiedel; Lang Tran; Agnes G Oomen; Peter M J Bos; Kerstin Hund-Rinke
Journal:  Int J Environ Res Public Health       Date:  2017-10-19       Impact factor: 3.390

Review 8.  Current Approaches and Techniques in Physiologically Based Pharmacokinetic (PBPK) Modelling of Nanomaterials.

Authors:  Wells Utembe; Harvey Clewell; Natasha Sanabria; Philip Doganis; Mary Gulumian
Journal:  Nanomaterials (Basel)       Date:  2020-06-29       Impact factor: 5.076

Review 9.  Research tools for extrapolating the disposition and pharmacokinetics of nanomaterials from preclinical animals to humans.

Authors:  Michael S Valic; Gang Zheng
Journal:  Theranostics       Date:  2019-05-18       Impact factor: 11.556

10.  Physiologically based pharmacokinetic modeling of nanoceria systemic distribution in rats suggests dose- and route-dependent biokinetics.

Authors:  Ulrika Carlander; Tshepo Paulsen Moto; Anteneh Assefa Desalegn; Robert A Yokel; Gunnar Johanson
Journal:  Int J Nanomedicine       Date:  2018-05-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.